Comparison of objective and subjective visual quality after flapless laser vision correction for mild to moderate myopia: SMILE vs PRK
Graefe's Archive for Clinical and Experimental Ophthalmology · 2023-06 · 261 (6) · 1731-1741
DOI: 10.1007/s00417-022-05937-7 ↗At a glance
Journal article in Graefe's Archive for Clinical and Experimental Ophthalmology, published online on 2023-01-18. Written by Ruiyu Zhang and 3 co-authors. Institution: Department of Ophthalmology, Peking University Third Hospital, No 49 Huayuan North Road, Haidian District, Beijing, 100191, China. Major MEDLINE topics: Photorefractive Keratectomy, Myopia. Cited 23 times so far (Crossref); 37 references.
Abstract (original language)
PURPOSE: To investigate the differences in surgical results and the objective and subjective quality of vision (QoV) of patients after small incision lenticule extraction (SMILE) versus alcohol-assisted photorefractive keratectomy (PRK). METHODS: Medical records of patients treated with SMILE and PRK were retrospectively examined. Visual quality, biometric parameters, Strehl ratio (SR), and corneal higher-order aberrations (HOAs) within a 6.0 mm area were recorded. The effective optical zone (EOZ) and decentration were measured using a tangential pre-post operation difference map. Subjective QoV and operation satisfaction were evaluated 6 months postoperatively using the Quality of Vision questionnaire. RESULTS: The study comprised 100 eyes treated with SMILE (preoperative mean spherical equivalent (SE), - 4.52 ± 0.81 dioptres (D)) and 69 eyes with PRK (mean SE, - 4.21 ± 1.25 D). Six months postoperatively, the EOZ reduction was significantly larger in the PRK group (P < 0.001). Decentrations were comparable between the groups. Regarding visual symptoms, monocular diplopia was more common following PRK (P = 0.02), and 98 (98.00%) SMILE-treated and 67 (97.10%) PRK-treated patients were satisfied with the QoV. Both groups demonstrated significant increases in total HOAs, coma, and spherical aberration (SA) at 6 months postoperatively compared to preoperatively (P < 0.001); these values were significantly higher in the PRK (P < 0.05) compared to the SMILE group. SR increased significantly only in the PRK group (P < 0.05). CONCLUSION: Although EOZ was more consistent with anticipated treatment and HOAs were fewer in SMILE, high patient-reported satisfaction and good corneal optical quality were achieved in both groups, indicating that both SMILE and alcohol-assisted PRK are excellent options for mild to moderate myopia correction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Ophthalmology, Peking University Third Hospital, No 49 Huayuan North Road, Haidian District, Beijing, 100191, China.
- Beijing Key Laboratory of Restoration of Damaged Ocular Nerves, Beijing, China.
- Department of Ophthalmology, Peking University Third Hospital, No 49 Huayuan North Road, Haidian District, Beijing, 100191, China. chenyueguo@263.net.
- Beijing Key Laboratory of Restoration of Damaged Ocular Nerves, Beijing, China. chenyueguo@263.net.
Cite
APA
Zhang, R., Zhang, Y., Yuan, Y., & Chen, Y. (2023). Comparison of objective and subjective visual quality after flapless laser vision correction for mild to moderate myopia: SMILE vs PRK. Graefe's Archive for Clinical and Experimental Ophthalmology, 261(6), 1731-1741. https://doi.org/10.1007/s00417-022-05937-7
Vancouver
Zhang R, Zhang Y, Yuan Y, Chen Y. Comparison of objective and subjective visual quality after flapless laser vision correction for mild to moderate myopia: SMILE vs PRK. Graefe's Archive for Clinical and Experimental Ophthalmology. 2023;261(6):1731-1741. doi:10.1007/s00417-022-05937-7
BibTeX
@article{Zhang2023,
author = {Zhang, Ruiyu and Zhang, Yu and Yuan, Yifei and Chen, Yueguo},
title = {Comparison of objective and subjective visual quality after flapless laser vision correction for mild to moderate myopia: SMILE vs PRK},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2023},
volume = {261},
number = {6},
pages = {1731--1741},
doi = {10.1007/s00417-022-05937-7}
}
EUVIMED